BioSpace News Archive

Press Releases

Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement

March 30, 2026
·
6 min read
Press Releases

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

March 30, 2026
·
11 min read
Press Releases

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

March 30, 2026
·
7 min read
Press Releases

Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease

March 30, 2026
·
5 min read
Press Releases

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

March 30, 2026
·
12 min read
Press Releases

Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI

March 30, 2026
·
9 min read
Press Releases

Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

March 30, 2026
·
6 min read
Press Releases

Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial

March 30, 2026
·
6 min read
Press Releases

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

March 30, 2026
·
5 min read
Press Releases

Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio

March 30, 2026
·
3 min read